Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
<p>Abstract</p> <p>Background</p> <p>Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions. The aim of this study was to determine the diagnostic utility of non-invasive markers of fibrosis, validated...
Main Authors: | Munteanu Mona, Tahiri Mohamed, Bonyhay Luninita, Imbert-Bismut Françoise, Messous Djamila, Charlotte Frederic, Massard Julien, Ratziu Vlad, Thabut Dominique, Cadranel Jean, Le Bail Brigitte, de Ledinghen Victor, Poynard Thierry |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-02-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/6/6 |
Similar Items
-
Meta-analyses of FibroTest diagnostic value in chronic liver disease
by: Bourliere Marc, et al.
Published: (2007-10-01) -
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
by: Messous Djamila, et al.
Published: (2011-04-01) -
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
by: Bismut Françoise, et al.
Published: (2010-04-01) -
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
by: Friedrich-Rust Mireen, et al.
Published: (2010-09-01) -
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
by: Friedrich-Rust, Mireen, et al.
Published: (2010)